You can talk to the chatbot like it's a friendly acquaintance, and it'll help you get a lot done. Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and ...

People who interact with chatbots for emotional support or other personal reasons are likelier to report symptoms of depression or anxiety, a new study finds. The researchers from Mass General Brigham ...

How does a cow scratch an itch on its back? An Austrian cow named Veronika has a solution that could change how we view livestock. For the past decade, Veronika has been observed by her owner ...

Veronika, a cow living in an idyllic mountain village in the Austrian countryside, has spent years perfecting the art of scratching herself with sticks, rakes, and deck brushes. Now that scientists ...

If you create tutorials or instructional content, clarity is king. Whether it’s for training new hires or content in a particular niche, clear instructional content reduces confusion and support ...

Q. I developed severe depression while taking Repatha, the injectable cholesterol-lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...

In mid-December 2025, an image (archived) circulated online purportedly showing U.S. President Donald Trump using a walker as a mobility aid. Keith Edwards, a Democratic political strategist, posted ...

Every 40 seconds, someone in the U.S. has a heart attack or stroke, and in most cases, it’s their first. 1 The good news? The risk for these devastating events can actually be significantly reduced by ...

In late-stage studies, Merck & Co.’s PCSK9-targeted pill achieved low-density lipoprotein cholesterol (LDL-C) reductions similar to those observed with existing injectables. The results from two phase ...

THOUSAND OAKS, Calif., Oct. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV ...

THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha ® (evolocumab). This follows ...